Conmed earnings were $64.1M for the trailing 12 months ending Sep 30, 2025, with -51.9% growth year over year. The latest CNMD earnings report on Sep 30, 2025 announced Q3 2025 earnings of $2.9M, down 86.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNMD reported annual earnings of $132.4M, with 105.4% growth.
CNMD past earnings growth
How has CNMD's earnings growth performed historically?
On CNMD's earnings call on Invalid Date, Conmed (NYSE: CNMD) reported Q3 2025 earnings per share (EPS) of $0.09, up 94.34% year over year. Total CNMD earnings for the quarter were $2.86 million. In the same quarter last year, Conmed's earnings per share (EPS) was $1.59.
As of the last Conmed earnings report, Conmed is currently profitable. Conmed's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $64.07 million, a 51.37% decrease year over year.
What was CNMD's earnings growth in the past year?
As of Conmed's earnings date in Invalid Date, Conmed's earnings has grown -51.87% year over year. This is 99.12 percentage points lower than the US Medical Devices industry earnings growth rate of 47.25%. CNMD earnings in the past year totalled $64.07 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.